J Montie
Overview
Explore the profile of J Montie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tewari A, Issa M, Stricker H, Peabody J, Pow-Sang J, Shukla A, et al.
Mol Urol
. 2002 Jan;
5(4):163-9.
PMID: 11790278
Background And Purpose: Despite many new procedures, radical prostatectomy remains one of the commonest methods of treating clinically localized prostate cancer. Both from the physician's and the patient's point of...
2.
Demers R, Tiwari A, Wei J, Weiss L, Severson R, Montie J
Cancer
. 2001 Dec;
92(9):2309-17.
PMID: 11745285
Background: After a surge in the incidence of prostate carcinoma in the early 1990s, diminishing rates of mortality became apparent in 1993. This decrease in mortality is unlikely to be...
3.
Campbell T, Blasko J, Crawford E, Forman J, Hanks G, Kuban D, et al.
Int J Cancer
. 2001 Jun;
96(3):198-209.
PMID: 11410889
The American Joint Committee on Cancer (AJCC) staging system for prostate cancer adopted in 1992 is based on tumor-node-metastasis (TNM) designations. It has been widely accepted for use in local...
4.
Prescott J, Montie J, Pugh T, McHugh T, Veltri R
Cancer
. 2001 Jun;
91(11):2127-35.
PMID: 11391594
Background: Mutations in the p53 tumor suppressor gene may correlate with an increased risk of recurrence and disease progression in patients with bladder carcinoma. The ability to accurately and sensitively...
5.
Crawford E, Batuello J, Snow P, Gamito E, McLeod D, Partin A, et al.
Cancer
. 2000 May;
88(9):2105-9.
PMID: 10813722
Background: The current study assesses artificial intelligence methods to identify prostate carcinoma patients at low risk for lymph node spread. If patients can be assigned accurately to a low risk...
6.
Rubin M, Bassily N, Sanda M, Montie J, Strawderman M, Wojno K
Am J Surg Pathol
. 2000 Feb;
24(2):183-9.
PMID: 10680885
Serum prostate-specific antigen (PSA) levels and the biopsy Gleason sum are used along with clinical staging to predict prostatectomy pathology results for men with localized prostate cancer. The additional predictive...
7.
Scher H, Bahnson R, Cohen S, Eisenberger M, Herr H, Kozlowski J, et al.
Oncology (Williston Park)
. 1998 Aug;
12(7A):225-71.
PMID: 9699218
Urothelial tumors represent a spectrum of diseases with a range of prognoses. Once a diagnosis is established at any point on the urothelial tract, the patient remains at risk for...
8.
Powell I, Heilbrun L, Sakr W, Grignon D, Montie J, Novallo M, et al.
Urology
. 1997 May;
49(5):726-31.
PMID: 9145978
Objectives: Several investigators have reported that African-American men with clinically localized prostate cancer have poorer survival than do white men. In addition, prostate cancer in African-American men is commonly diagnosed...
9.
Ravery V, Grignon D, Angulo J, Pontes E, Montie J, Crissman J, et al.
Urol Res
. 1997 Jan;
25(1):9-17.
PMID: 9079740
Introduction: Determination of the risk of invasive bladder tumors progressing is still imprecise due to the heterogeneous biological behavior of this neoplasm. The goals of this study were to evaluate...
10.
Porter A, Zimmerman J, Ruffin M, Chernew M, Callaghan C, Davis R, et al.
Urology
. 1996 Oct;
48(4):519-33; discussion 533-4.
PMID: 8886054
No abstract available.